LEAD Program @ UCSF Department of Psychiatry

The Learning for Early Careers in Addiction & Diversity (LEAD) Program leads the way in substance use disorder research to ensure improved care for everyone.

[LEAD Program @ UCSF Department of Psychiatry @ucsf_lead]

https://t.co/DA028hlNeZ

Researchers identify brain network that is uniquely activated through injection vs. oral drug use

[LEAD Program @ UCSF Department of Psychiatry @ucsf_lead]

https://t.co/DA028hlNeZ

Researchers identify brain network that is uniquely activated through injection vs. oral drug use

[LEAD Program @ UCSF Department of Psychiatry @ucsf_lead]

Telehealth supports retention in treatment for opioid use disorder

Federally funded study provides additional evidence supporting expanded use of telehealth services for opioid use disorder-related care

https://t.co/kJzuLinyg5

[LEAD Program @ UCSF Department of Psychiatry @ucsf_lead]

@aleena1623 @ElisaTruccoPhD @RSAposts @rsa_education @apadivision50 Hi Aleena,
The LEAD Program requires candidates to be US Citizens or permanent residents.

[LEAD Program @ UCSF Department of Psychiatry @ucsf_lead]

https://t.co/uCs4FMgSZ8

[LEAD Program @ UCSF Department of Psychiatry @ucsf_lead]

Only 1 in 5 U.S. adults with opioid use disorder received medications to treat it in 2021
https://t.co/Fzmgh493Tc

[LEAD Program @ UCSF Department of Psychiatry @ucsf_lead]

Buprenorphine initiation in the ER found safe and effective for individuals with opioid use disorder who use fentanyl https://t.co/eC8e0z6lFl

[LEAD Program @ UCSF Department of Psychiatry @ucsf_lead]

Increased Use of Telehealth Services and Medications for Opioid Use Disorder During the COVID-19 Pandemic Associated with Reduced Risk for Fatal Overdose https://t.co/z4VZO0SVAE

[LEAD Program @ UCSF Department of Psychiatry @ucsf_lead]

FDA Approves First Over-the-Counter Naloxone Nasal Spray https://t.co/fpPRLTB5AG

[LEAD Program @ UCSF Department of Psychiatry @ucsf_lead]

America's Opioid Ecosystem: How Leveraging System Interactions Can Help Curb Addiction, Overdose, and Other Harms https://t.co/MeoHb25IAH via @RANDCorporation

[LEAD Program @ UCSF Department of Psychiatry @ucsf_lead]

X-Waiver No Longer Required for Buprenorphine Prescribing for OUD https://t.co/V3dFNOtlJP

[LEAD Program @ UCSF Department of Psychiatry @ucsf_lead]

Long-acting antiretroviral therapy suppresses HIV among people with unstable housing, mental illnesses, substance use https://t.co/NUQwEtlv1a

[LEAD Program @ UCSF Department of Psychiatry @ucsf_lead]

Psychedelic research: balancing trippyness with a new scientific rigor – The Conversation Weekly podcast transcript https://t.co/vzaDPTLgg9 via @ConversationUK

[LEAD Program @ UCSF Department of Psychiatry @ucsf_lead]

Has anyone read "Dreamland: The True Tale of America's Opiate Epidemic" by Sam Quinones?

Do you think his portrayal is accurate?

https://t.co/4Rf5ViFfGt

[LEAD Program @ UCSF Department of Psychiatry @ucsf_lead]

Check out this article: https://t.co/O3vi7VjeLD

[NIDAnews @NIDAnews]

🆕 NIDA-supported study in @JRuralHealth: researchers evaluated associations between #technology access prior to #COVID19 and engagement in substance use disorder (#SUD) treatment among individuals who use drugs in rural U.S. communities. https://t.co/elXr53vn7M (1/4)

[Noa Krawczyk @NoaKrawczyk]

Check out our new @Health_Affairs blog post where we outline how #opioid settlement funds can be invested to address #overdose and #healthEquity in the hardest-hit communities. Always such an honor and pleasure to work and learn from @DrAyanaJordan & @Magda_Cerda!

[LEAD Program @ UCSF Department of Psychiatry @ucsf_lead]

California Invests $52 Million in Opioid Prevention and Treatment: California Continues Statewide Efforts to Combat the Opioid Crisis, Keep California Communities Safe, and Provide Recovery Resources
https://t.co/i8c8cji3w0

[LEAD Program @ UCSF Department of Psychiatry @ucsf_lead]

https://t.co/Nu5emr24jR

[LEAD Program @ UCSF Department of Psychiatry @ucsf_lead]

https://t.co/lZZ9Gcqf9S